UniSuper Management Pty Ltd increased its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 14.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,789 shares of the healthcare conglomerate’s stock after buying an additional 12,587 shares during the period. UniSuper Management Pty Ltd’s holdings in UnitedHealth Group were worth $51,997,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in the company. State Street Corp grew its holdings in shares of UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock worth $11,440,133,000 after buying an additional 318,039 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock valued at $4,884,019,000 after acquiring an additional 193,800 shares during the last quarter. Bank of New York Mellon Corp increased its stake in UnitedHealth Group by 0.5% during the fourth quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate’s stock worth $4,012,218,000 after acquiring an additional 36,394 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of UnitedHealth Group by 3.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,223,331 shares of the healthcare conglomerate’s stock valued at $3,148,134,000 after purchasing an additional 182,361 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Price Performance
NYSE UNH opened at $518.10 on Thursday. The company has a market cap of $473.92 billion, a PE ratio of 33.43, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm’s 50 day moving average price is $508.60 and its 200-day moving average price is $545.37.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group’s payout ratio is 54.19%.
Insiders Place Their Bets
In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.
Analysts Set New Price Targets
Several analysts recently weighed in on UNH shares. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.
View Our Latest Stock Analysis on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- What is the MACD Indicator and How to Use it in Your Trading
- Energy Transfer: Powering Data With Dividends and Diversification
- The How And Why of Investing in Oil Stocks
- Qualcomm Stock Is Coiling for a Breakout
- Trading Halts Explained
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.